
Revised Schedule M: a guide to India’s GMP rules for drugmakers in 2026
India's revised drug manufacturing rules now apply to every licensed maker. Here is what changed, who had which deadline, how enforcement has worked and what to watch.
Medicines makers and life sciences companies: approvals, manufacturing, pricing and launches.

India's revised drug manufacturing rules now apply to every licensed maker. Here is what changed, who had which deadline, how enforcement has worked and what to watch.

Wasfaty sends government patients' prescriptions to more than 5,000 private pharmacies.

How India's drug price order works in 2026: ceiling prices for essential medicines, the annual inflation revision, the 10% cap on other…

Maharashtra Chief Minister Devendra Fadnavis opened the office, Indian Pharma Post reported.

The Spanish drugmaker, which sells more than 100 product references in the region, plans secondary packaging and batch release next, with local…

The MHRA's review covered 28 antidepressants authorised in the UK.

The notice to Hetero Healthcare, Akums subsidiary Pure and Cure and Abaris covers Rs 18.95 crore of alleged overcharging on batches made…

An official Punjab statement, reported by PTI and carried by Medical Dialogues, says 16,788 inspections from April 2025 to September 2026 led…
The US FDA issued a Form 483 with one observation after an unannounced inspection of Rubicon's Satara plant from 5 to 9…

A US FDA pre-approval inspection of Dr. Reddy's FTO-11 site at Pydibhimavaram from 5 to 7 October 2026 ended with a Form…

The MHRA granted Atnahs Pharma UK a marketing authorisation for Korjuny on 2 October 2026.

The SFDA granted Breakthrough Medicine designation to Roche's Wilsirdli (giredestrant) on 7 October 2026 for two ER+/HER2- breast cancer uses.

Lupin says the DCGI-approved twice-daily inhaler combines glycopyrronium, formoterol and fluticasone in one fixed dose.
In a hospital, the handover is when one shift tells the next what changed and what to watch. Ours does the same for the business of healthcare, every weekday morning once it launches.
One email each weekday after launch. Unsubscribe at any time.